Avadel Pharmaceuticals (AVDL) Q3 2024 Earnings

8AugConfirmed
Q3 2023
Q4 2023
Q2 2024
Q3 2024
-0.41
-0.32
-0.23
-0.14

Details

Expected EPS
-0.178889
Actual EPS
-0.14
Surprise EPS
0.04
Surprise Percent
+21.74%

Description

Avadel Pharmaceuticals (AVDL) has reported earnings of -0.14 per share for Q3 2024.

0 Comments

Share your thoughts